Regulatory Approval and Closing Risks in the Sale of Arm to NVIDIA
First written in FY2021-Q2. 1 of 3 entries say "Restated". Latest entry: FY2022-Q3.
SoftBank Group Corp. moved to the "Worse" side of this theme in 2022.
0 other companies' latest entry also says "Materialised".
- FY2022-Q3MaterialisedAnnual report
「The Company and NVIDIA continued to make good-faith efforts to complete the transaction, but in light of regulatory issues, they agreed to terminate the agreement on 8 February 2022.」
The agreement for the sale of Arm to NVIDIA was terminated due to regulatory issues. The risks associated with regulatory approvals in multiple jurisdictions and closing materialised in the transaction’s failure to complete. - FY2021-Q3RestatedAnnual report
「The transaction was subject to approval by the necessary regulatory authorities, including those in the UK, China, the EU and the US, and satisfaction of other customary closing conditions. Completion was expected to take approximately 18 months from the signing of the agreement.」
The sale of Arm to NVIDIA continued to carry the risk of requiring regulatory approvals in multiple jurisdictions and other closing conditions, with completion expected to take approximately 18 months. - FY2021-Q2First statedAnnual report
「The transaction was subject to approval by the necessary regulatory authorities, including those in the UK, China, the EU and the US, and satisfaction of other customary closing conditions. Completion was expected to take approximately 18 months.」
The sale of Arm was subject to regulatory approvals in multiple jurisdictions and other closing conditions, with completion expected to take approximately 18 months, creating a newly identified transaction risk. The ISG business was expected to be separated from Arm before completion and excluded from the sale.